Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100OXC2
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥76.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥18.5bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥4.4bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥17.5bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.7bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥4.7bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥3.4bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥165.1bnat 2022-06-30Cons.Assets
Total assets¥165.2bnat 2022-03-31Cons.Assets
Total assets¥163.3bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥27.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥26.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets
Net assets / equity¥138.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥135.7bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥60.0bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥61.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥251.432021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.782021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio83.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥17.9bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥17.9bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥4.1bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2021-04-01 → 2021-06-30¥589m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2021-04-01 → 2021-06-30¥589m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2021-04-01 → 2021-06-30¥299m
—segment totalrevenue2021-04-01 → 2021-06-30¥18.5bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥18.5bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥4.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant8082800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant8082800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1759
Cash and depositsPrior1YearInstant61025000000JPY
Cash and depositsCurrentQuarterInstant59999000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant20260000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant20500000000JPY
Short term investment securitiesPrior1YearInstant13599000000JPY
Short term investment securitiesCurrentQuarterInstant13699000000JPY
Merchandise and finished goodsPrior1YearInstant5807000000JPY
Merchandise and finished goodsCurrentQuarterInstant6890000000JPY
Work in processPrior1YearInstant2964000000JPY
Work in processCurrentQuarterInstant2643000000JPY
Raw materials and suppliesPrior1YearInstant6209000000JPY
Raw materials and suppliesCurrentQuarterInstant6189000000JPY
Other caPrior1YearInstant746000000JPY
Other caCurrentQuarterInstant835000000JPY
Allowance for doubtful accounts caPrior1YearInstant－JPY
Allowance for doubtful accounts caCurrentQuarterInstant-0JPY
Current assetsPrior1YearInstant110613000000JPY
Current assetsCurrentQuarterInstant110758000000JPY
Buildings and structures netPrior1YearInstant17142000000JPY
Buildings and structures netCurrentQuarterInstant16926000000JPY
Other net ppePrior1YearInstant8591000000JPY
Other net ppeCurrentQuarterInstant8370000000JPY
Property plant and equipmentPrior1YearInstant25734000000JPY
Property plant and equipmentCurrentQuarterInstant25296000000JPY
In process research and development iaPrior1YearInstant7300000000JPY
In process research and development iaCurrentQuarterInstant7300000000JPY
Other iaPrior1YearInstant936000000JPY
Other iaCurrentQuarterInstant970000000JPY
Intangible assetsPrior1YearInstant8236000000JPY
Intangible assetsCurrentQuarterInstant8270000000JPY
Investment securitiesPrior1YearInstant17093000000JPY
Investment securitiesCurrentQuarterInstant17224000000JPY
Other ioaPrior1YearInstant3503000000JPY
Other ioaCurrentQuarterInstant3550000000JPY
Investments and other assetsPrior1YearInstant20596000000JPY
Investments and other assetsCurrentQuarterInstant20774000000JPY
Noncurrent assetsPrior1YearInstant54567000000JPY
Noncurrent assetsCurrentQuarterInstant54342000000JPY
AssetsPrior1YearInstant165181000000JPY
AssetsCurrentQuarterInstant165101000000JPY
Notes and accounts payable tradePrior1YearInstant5861000000JPY
Notes and accounts payable tradeCurrentQuarterInstant6556000000JPY
Electronically recorded obligations operating clPrior1YearInstant78000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant73000000JPY
Short term loans payablePrior1YearInstant3850000000JPY
Short term loans payableCurrentQuarterInstant3850000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass